OBSTETRICS & GYNAECOLOGY

SeraSeal™ is extremely effective in both obstetrics and gynaecological surgical procedures, such as: Vaginal delivery: arrests the bleeding from a episotomy, which is a surgical incision of the perineum to enlarge the vaginal opening during the birthing process. C-section: arrest the bleeding to both the uterus and abdominal wall. In Gynecology, procedures such as Myomectomy: the removal of uterine fibroid tumors. Dilation and Curettage (D&C), most common procedure. Performed to remove a portion of the uterine lining, abortion, miscarriage, molar pregnancy,and retained placenta. Hysterectomy: removal of the uterus, Ovariectomy: removal of the ovarian cysts or tumor. It should be noted SeraSeal™ can be delivered through a hysteroscopy device, and SeraSeal™ reduces blood loss by 90% in at least upto 40% surgical procedures.

During childbirth, Cesarean section (CS) surgeries, average blood loss has been observed as 500-1500 ml (1-3 units of blood). The uterus is perfused at a rate of 500-750 ml/min, resulting in an average blood loss of approximately 1000 ml (2 units). Vaginal delivery blood loss averages 500 ml; Vaginal delivery with episiotomy and forceps average 555 ml (11% higher) and Postpartum hemorrhage around 1-5%. Typically, blood transfusion is required where there is a blood loss of 2 or more units. Therefore, on an average of 70,000 deliveries/day in India and 40% of deliveries being CS, SeraSeal™ could save upto 28,000 units of blood/day. This is both a large cost-saving, as well as, a significant reduction of risk to the patient. Statistically, approximately 25% of women have a pelvic floor disorder, and 1 in 5 (20%) will have surgery, such as hysterectomy, ovariectomy, dilatation, curettage (D&C), polypectomy, and more. Therefore, In India, where 45% are women, this translates into 52+million gynaecological surgical cases annually, where SeraSeal™ can be used.